Emerging strategies and options: Difference between revisions
From MalariaETC
No edit summary |
No edit summary |
||
| Line 12: | Line 12: | ||
---- | ---- | ||
<span style="font-size:90%">'''Multiplexed detection strategies''' | <span style="font-size:90%">'''Multiplexed detection strategies''' | ||
</br>These may be used in some circumstances to optimise performance according to local requirements:</br></br> (a) Where both ''P.falciparum'' and ''P.vivax'' are highly prevalent, then tests with specificity for each species may prove valuable - ''P.falciparum'' (HRP2) and ''P.vivax'' (Pv-pLDH) may be combined with or without a | </br>These may be used in some circumstances to optimise performance according to local requirements:</br></br> (a) Where both ''P.falciparum'' and ''P.vivax'' are highly prevalent, then tests with specificity for each species may prove valuable - ''P.falciparum'' (HRP2) and ''P.vivax'' (Pv-pLDH) may be combined with or without a pan-specific antibody. This can offer some advantages in detecting dual infection by the two species.</br></br>(b) Where HRP2 deletion are frequent, they may cause a high risk for test failure, tests multiplexed to select for Pf-pLDH and HRP2 may improve detection in these circumstances. | ||
|} | |} | ||
Revision as of 09:55, 29 September 2024
Navigation
1. Main Malaria Index
2. RDT main page
3. RDT Test Design
Current page: Emerging Strategies for RDT Design
| Emerging Strategies for RDT design
Multiplexed detection strategies
|